Plain-English translation of NCT04611113 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a special nutritional drink called Impact® — enriched with immune-supporting ingredients like omega-3 fatty acids and arginine — can help patients with head and neck cancer tolerate chemotherapy and radiation better. Half the patients will receive this specialized drink, and half will receive a standard high-protein nutritional supplement. Both groups will also receive nutritional counseling to support their health during treatment.
Cancer treatment can be hard on the body and make it difficult for patients to eat well and maintain their strength. Researchers believe that the medication may help reduce inflammation and support the immune system, which could help patients handle treatment better and recover faster.
You likely qualify if…
You likely don't qualify if…
You would start taking the assigned nutritional supplement about 10–15 days before your cancer treatment begins and continue until your treatment ends. You'll have two servings daily of either the specialized immune-boosting drink or a standard high-protein supplement, along with personalized nutrition counseling. Throughout your treatment, you'll complete scheduled measurements and visits to help researchers track how well you're tolerating your cancer therapy.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
Italy